Page 3 - Biopharma Development News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Biopharma Development. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Biopharma Development Today - Breaking & Trending Today

Astellas' VEOZAH™ (fezolinetant) Approved by U.S. FDA for Treatment of Vasomotor Symptoms Due to Menopause

Published: May 12, 2023

 VEOZAH is first-in-class treatment option to reduce the frequency and severity of moderate to severe VMS due to menopause TOKYO, May 12, 2023 /PRNewswire/ -- Astellas Pharma Inc. today... | June 14, 2023

Source: marketscreener.com

Related Topics:

United StatesGenevieve Neal PerryNaoki OkamuraAstellas PharmaPrnewswire Astellas Pharma IncHealth Qual Life OutcomesSchool Of Medicine Department ObstetricsAstellas Pharma IncJ Public HealthDrug AdministrationAstellas IncHead Of Biopharma DevelopmentFull Interactive MultimediaMedicine DepartmentMarci EnglishVice PresidentBiopharma DevelopmentAstella New Drug ApplicationProvides UpdateFezolinetant New Drug ApplicationPrescribing InformationPatient Product InformationFocus Area ApproachEqual LifePenn Ovarian Aging Study